1-9 of 9
Mette Ilander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Analysis of Immune Recognition in Chronic Myeloid Leukemia Patients Following Tyrosine Kinase Inhibitor Discontinuation

Jani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos, Sofia Forstén, Rebecca Warfvinge, Olli Dufva, Jonas Bouhlal, Parashar Dhapola, Hanna Duàn, Essi Laajala, Tiina Kasanen, Jay Klievink, Mette Ilander, Taina Jaatinen, Ulla Olsson-Strömberg, Henrik Hjorth-Hansen, Andreas Burchert, Göran Karlsson, Anna Kreutzman, Harri Lähdesmäki, Satu Mustjoki
Journal: Blood
Blood (2023) 142 (Supplement 1): 3146.
https://doi.org/10.1182/blood-2023-185630
Published: 2023
Journal Articles

Single-Cell Characterization of the Immune and Leukemic Cells Following Anti-TIM3 and Hypomethylating Agent Combination Therapy in Patients with AML or MDS

Jani Huuhtanen, Oscar Brück, Karita Peltonen, Anna Kreutzman, Olli Dufva, Matti Kankainen, Mette Ilander, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Mika Kontro, Elena J Orlando, Viviana Cremasco, Joel Wagner, Marc Pelletier, Harri Lähdesmäki, Catherine A. Sabatos-Peyton, Mikael L. Rinne, Kimmo Porkka, Satu Mustjoki
Journal: Blood
Blood (2021) 138 (Supplement 1): 801.
https://doi.org/10.1182/blood-2021-147150
Published: 2021
Journal Articles

Single-Cell Roadmap of Immune Cell Response in Chronic Myeloid Leukemia

Jani Huuhtanen, Jason Theodoropoulos, BSc, Rebecca Warfvinge, MSc, Andreas Burchert, MD, Tiina Kasanen, Jay Klievink, MSc, Shady Adnan Awad, MD, Olli Dufva, MD, Mette Ilander, PhD, Taina Jaatinen, Ulla Olsson-Strömberg, MD PhD, Henrik Hjorth-Hansen, MD, Göran Karlsson, PhD, Harri Lähdesmäki, PhD, Anna Kreutzman, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-139134
Published: 2020
Journal Articles

CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers

Olli Dufva, Khalid Saeed, Sara Gandolfi, MD, Michal Sheffer, PhD, Jay Klievink, Petri Pölönen, MSc, Tiina Hannunen, Mette Ilander, PhD, Pekka Ellonen, BSc, Matti Kankainen, PhD, Dean Anthony Lee, MD PhD, Constantine S. Mitsiades, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3597.
https://doi.org/10.1182/blood-2019-129837
Published: 2019
Journal Articles

Genome-Scale CRISPR Screens Identify Essential Genes for Sensitivity to Natural Killer Cells in Hematological Malignancies

Olli Dufva, Jay Klievink, Khalid Saeed, Matti Kankainen, PhD, Mette Ilander, PhD, Tiina Hannunen, Sonja Lagström, Pekka Ellonen, BSc, Dean Anthony Lee, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 732.
https://doi.org/10.1182/blood-2018-99-117985
Published: 2018
Journal Articles

Quantitative Multiplex Immunohistochemistry Identifies Immunosuppression in the AML Bone Marrow and NK-Cells As Prognostic Biomarker in Intermediate-Risk Patients

Oscar Brück, MD, Olli Dufva, Sami Blom, MSc, Riku Turkki, MSc, Mette Ilander, PhD, Sanna M. Siitonen, MD PhD, Panu Kovanen, MD PhD, Celine Pallaud, PhD, Pedro Marques Ramos, PhD, Hanna Lähteenmäki, Katja Välimäki, Antonio Ribeiro, BSc, Olli Kallioniemi, MD PhD, Kimmo Porkka, MD PhD, Teijo Pellinen, PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2774.
https://doi.org/10.1182/blood-2018-99-116628
Published: 2018
Journal Articles

Plasma Fms-Related Tyrosine Kinase 3 Ligand (Flt3L) Levels at Diagnosis Correlate with Treatment Response in Chronic Myeloid Leukemia

Bhagwan Yadav, PhD, Mette Ilander, PhD, Anna Kreutzman, PhD, Henrik Hjorth-Hansen, MD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1602.
https://doi.org/10.1182/blood.V130.Suppl_1.1602.1602
Published: 2017
Journal Articles

Effects of Dasatinib and Interferon-α Combination Treatment on the Immune System in CML

Mette Ilander, PhD, Hanna Lähteenmäki, MSc, Ulla Olsson-Stromberg, MD PhD, Jesper Stentoft, MD PhD, Johan Richter, MD, Perttu Koskenvesa, MD, Martin Höglund, MD PhD, Arta Dreimane, MD PhD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, Björn T. Gjertsen, Franz X. Gruber, Leif Stenke, MD PhD, Kristina Myhr-Eriksson, MD, Berit Markevärn, MD, Anna Lubking, MD, Hanne Vestergaard, MD PhD, Lene Udby, MD, Ole Weis Bjerrum, MD, Henrik Hjorth-Hansen, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 627.
https://doi.org/10.1182/blood.V128.22.627.627
Published: 2016
Journal Articles

Mature, Adaptive-like CD56 DIM NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Mette Ilander, Heinrich Schlums, Ulla Olsson-Strömberg, Hanna Lähteenmäki, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, Martin Höglund, Ass Prof, Berit Markevärn, Anders Själander, Kourosh Lotfi, Claes Malm, Anna Lubking, MD, Marja Ekblom, Elena Holm, Mats Björeman, Sören Lehmann, Leif Stenke, MD PhD, Lotta Ohm, Waleed Majeed, MD, Martin C. Muller, Hans Ehrencrona, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD Professor, Kimmo Porkka, MD PhD, Joelle Guilhot, PhD, Yenan Bryceson, Johan Richter, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 343.
https://doi.org/10.1182/blood.V126.23.343.343
Published: 2015